Andersons Inc. Amends 8-K Filing for July 31, 2025
Ticker: ANDE · Form: 8-K/A · Filed: Oct 14, 2025 · CIK: 821026
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Andersons Inc. filed an amendment to its July 31, 2025 8-K, mostly for financial docs.
AI Summary
The Andersons, Inc. filed an amendment (8-K/A) on October 14, 2025, to its current report originally dated July 31, 2025. This amendment primarily concerns the filing of financial statements and exhibits related to the period ending July 31, 2025. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates an update to previously submitted information, specifically regarding financial statements and exhibits, which is crucial for investors to have the most current and accurate data.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, primarily for administrative purposes related to financial statements and exhibits, and does not appear to introduce new material risks.
Key Players & Entities
- The Andersons, Inc. (company) — Registrant
- July 31, 2025 (date) — Date of earliest event reported
- October 14, 2025 (date) — Filing date of the amendment
FAQ
What is the purpose of this 8-K/A filing?
The purpose of this 8-K/A filing is to amend the current report originally filed on July 31, 2025, specifically to include financial statements and exhibits.
What is the exact date of the earliest event reported in this amendment?
The date of the earliest event reported in this amendment is July 31, 2025.
When was this amendment filed with the SEC?
This amendment was filed with the SEC on October 14, 2025.
What is the company's principal executive office address?
The company's principal executive office address is 1947 Briarfield Boulevard, Maumee, Ohio 43537.
What is the Standard Industrial Classification code for The Andersons, Inc.?
The Standard Industrial Classification code for The Andersons, Inc. is 5150, which corresponds to WHOLESALE-FARM PRODUCT RAW MATERIALS.
Filing Stats: 865 words · 3 min read · ~3 pages · Grade level 9.7 · Accepted 2025-10-14 08:46:44
Key Financial Figures
- $0.00 — nge on which registered: Common stock, $0.00 par value, $0.01 stated value ANDE The
- $0.01 — stered: Common stock, $0.00 par value, $0.01 stated value ANDE The NASDAQ Stock Mark
- $425.0 m — ng 49.9% ownership interest in TAMH for $425.0 million, inclusive of $40.0 million of wo
- $40.0 million — n TAMH for $425.0 million, inclusive of $40.0 million of working capital. The transaction clo
- $56.6 million — ld have been adjusted to reclassify the $56.6 million in net income attributable to noncontro
- $140.0 million — nded December 31, 2024, would have been $140.0 million. This amount includes pro forma adjustm
- $30.7 million — mount includes pro forma adjustments of $30.7 million for financing costs associated with usi
- $0 — nings per share would have increased by $0.76, amounting to $4.11 and $4.08 per sh
- $4.11 — d have increased by $0.76, amounting to $4.11 and $4.08 per share, respectively. Fo
- $4.08 — reased by $0.76, amounting to $4.11 and $4.08 per share, respectively. For the six
- $17.4 million — ld have been adjusted to reclassify the $17.4 million in net income attributable to noncontro
- $15.6 million — o controlling interests would have been $15.6 million. This figure reflects a similar pro for
- $9.9 million — lects a similar pro forma adjustment of $9.9 million for financing costs and resulting impac
- $0.46 — d have increased by $0.22, amounting to $0.46 per share. If the transaction had occ
- $351.0 m — flected an adjustment to reduce cash by $351.0 million, increase short-term debt by $74.
Filing Documents
- ande-20250731.htm (8-K/A) — 28KB
- ande-20250731_g1.jpg (GRAPHIC) — 118KB
- 0000821026-25-000193.txt ( ) — 436KB
- ande-20250731.xsd (EX-101.SCH) — 2KB
- ande-20250731_def.xml (EX-101.DEF) — 4KB
- ande-20250731_lab.xml (EX-101.LAB) — 25KB
- ande-20250731_pre.xml (EX-101.PRE) — 14KB
- ande-20250731_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (b) Pro Forma Financial Information: On July 31, 2025, the Company entered into the Purchase Agreement with Marathon to acquire the remaining 49.9% ownership interest in TAMH for $425.0 million, inclusive of $40.0 million of working capital. The transaction closed on July 31, 2025. Prior to the transaction date, TAMH was previously consolidated into the Company's financial statements, thus historical financial statements are not required. Assuming the transaction had occurred on January 1, 2024, the pro forma income statement would have been adjusted to reclassify the $56.6 million in net income attributable to noncontrolling interests as net income attributable to controlling interests. As a result, pro forma net income attributable to controlling interests for the year ended December 31, 2024, would have been $140.0 million. This amount includes pro forma adjustments of $30.7 million for financing costs associated with using cash on hand and additional borrowings from existing credit facilities to acquire the remaining equity interest in TAMH, as well as the resulting impact on the Company's income tax expense. Pro forma basic and diluted earnings per share would have increased by $0.76, amounting to $4.11 and $4.08 per share, respectively. For the six months ended June 30, 2025, the pro forma income statement would have been adjusted to reclassify the $17.4 million in net income attributable to noncontrolling interests as net income attributable to controlling interests. As a result, pro forma net income attributable to controlling interests would have been $15.6 million. This figure reflects a similar pro forma adjustment of $9.9 million for financing costs and resulting impact to the Company's income tax expense, stemming from the acquisition of the remaining equity interest in TAMH. Pro forma basic and diluted earnings per share would have increased by $0.22, amounting to $0.46 per share. If the transaction h
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. The Andersons, Inc. October 14, 2025 By: /s/ Brian A. Valentine Brian A. Valentine Executive Vice President and Chief Financial Officer